LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 126 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 4.22 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $41,000 | -84.7% | 20,677 | -57.1% | 0.06% | +281.2% |
| Q1 2019 | $268,000 | -10.7% | 48,152 | +70.8% | 0.02% | +14.3% |
| Q3 2018 | $300,000 | -41.5% | 28,200 | -34.1% | 0.01% | -33.3% |
| Q2 2018 | $513,000 | +10.3% | 42,800 | -21.1% | 0.02% | +10.5% |
| Q1 2018 | $465,000 | +48.6% | 54,266 | +71.0% | 0.02% | +35.7% |
| Q4 2017 | $313,000 | -44.6% | 31,733 | -7.8% | 0.01% | -53.3% |
| Q2 2017 | $565,000 | +59.6% | 34,400 | +39.3% | 0.03% | +87.5% |
| Q1 2017 | $354,000 | -25.5% | 24,700 | -28.2% | 0.02% | -42.9% |
| Q4 2016 | $475,000 | +173.0% | 34,400 | +136.0% | 0.03% | +250.0% |
| Q1 2016 | $174,000 | – | 14,574 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |